Please enable JavaScript to continue using this application.

Compare $IMRX vs $TLSI | Chartloom

Compare

$IMRX vs $TLSI

Immuneering Corp · TriSalus Life Sciences Inc

IMRX

Immuneering Corp

TLSI

TriSalus Life Sciences Inc

Compare $IMRX vs $TLSI

Comparing Immuneering Corp and TriSalus Life Sciences Inc

IMRXImmuneering Corp

TLSITriSalus Life Sciences Inc

IMRXImmuneering Corp

Market cap

$255M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-40.5%

52W performance

-39.4%

FCF yield

-22.4%

TLSITriSalus Life Sciences Inc

Market cap

$249M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.61x

Rev growth (TTM)

25.2%

YTD performance

-33.4%

52W performance

-16.3%

FCF yield

-9.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IMRX

TLSI

Detailed metrics comparison

IMRX

Immuneering Corp

TLSI

TriSalus Life Sciences Inc

Market Cap

IMRX$255M

TLSI$249M

Enterprise Value

IMRX$214M

TLSI$236M

Price

IMRX$3.94

TLSI$4.06

P/E Ratio

IMRXN/A

TLSIN/A

P/S Ratio

IMRX526.64x

TLSI5.53x

EV/Sales

IMRX443.99x

TLSI5.24x

EV/EBITDA

IMRX0.00x

TLSI0.00x

P/B Ratio

IMRX1.38x

TLSI40.61x

P/FCF Ratio

IMRXN/A

TLSIN/A

EV/FCF

IMRX-3.75x

TLSI-10.14x

PEG Ratio

IMRXN/A

TLSIN/A

Forward P/E (NTM)

IMRXN/A

TLSIN/A

Forward P/S (NTM)

IMRXN/A

TLSI3.61x

Revenue (TTM)

IMRX$0

TLSI$45M

Revenue Growth (YoY)

IMRXN/A

TLSI25.2%

Forward Rev Growth

IMRX100.5%

TLSI40.1%

Gross Margin (TTM)

IMRX28.0%

TLSI85.8%

Operating Margin (TTM)

IMRX0.0%

TLSI0.0%

EBITDA Margin (TTM)

IMRX0.0%

TLSI-66.4%

Net Margin (TTM)

IMRX0.0%

TLSI-130.2%

FCF Margin (TTM)

IMRXN/A

TLSI-51.6%

Net Income (TTM)

IMRX$-57M

TLSI$-59M

FCF (TTM)

IMRX$-57M

TLSI$-23M

EPS (TTM)

IMRX-$0.89

TLSI-$1.01

ROE (TTM)

IMRX-2715.0%

TLSI-7902.0%

ROA (TTM)

IMRX-2574.0%

TLSI-5499.0%

ROIC (TTM)

IMRX-2715.0%

TLSI-1789.0%

Cash

IMRX$41M

TLSI$46M

Debt

IMRX$0

TLSI$33M

Net Cash/Debt

IMRX$41M

TLSI$13M

Current Ratio (TTM)

IMRX19.47x

TLSI5.35x

Quick Ratio (TTM)

IMRX18.47x

TLSI4.72x

Debt/Equity (TTM)

IMRX0.00x

TLSI5.05x

Debt/Assets (TTM)

IMRX0.0%

TLSI0.0%

Interest Coverage (TTM)

IMRXN/A

TLSIN/A

Net Debt/EBITDA (TTM)

IMRX0.00x

TLSI0.00x

Beta

IMRX0.34

TLSI0.46

52W Performance

IMRX-39.4%

TLSI-16.3%

YTD Performance

IMRX-40.5%

TLSI-33.4%

% from 52W High

IMRX-53.5%

TLSI-48.9%

% from 52W Low

IMRX9.4%

TLSI84.5%

Asset Turnover (TTM)

IMRX0.00x

TLSI0.88x

FCF Yield (TTM)

IMRX-22.4%

TLSI-9.3%

Earnings Yield (TTM)

IMRX-22.5%

TLSI-23.5%

Dividend Yield (TTM)

IMRXN/A

TLSIN/A

Rule of 40

IMRX0.0

TLSI-26.4

EV/GP/RG

IMRXN/A

TLSI0.11

Ticker research

View IMRX research View TLSI research

Metric	IMRX Immuneering Corp	TLSI TriSalus Life Sciences Inc
Market & Valuation
Market Cap	$255M	$249M
Enterprise Value	$214M	$236M
Price	$3.94	$4.06
P/E Ratio	N/A	N/A
P/S Ratio	526.64x	5.53x
EV/Sales	443.99x	5.24x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.38x	40.61x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.75x	-10.14x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.61x
Revenue & Growth
Revenue (TTM)	$0	$45M
Revenue Growth (YoY)	N/A	25.2%
Forward Rev Growth	100.5%	40.1%
Profitability
Gross Margin (TTM)	28.0%	85.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-66.4%
Net Margin (TTM)	0.0%	-130.2%
FCF Margin (TTM)	N/A	-51.6%
Net Income (TTM)	$-57M	$-59M
FCF (TTM)	$-57M	$-23M
EPS (TTM)	-$0.89	-$1.01
ROE (TTM)	-2715.0%	-7902.0%
ROA (TTM)	-2574.0%	-5499.0%
ROIC (TTM)	-2715.0%	-1789.0%
Financial Health
Cash	$41M	$46M
Debt	$0	$33M
Net Cash/Debt	$41M	$13M
Current Ratio (TTM)	19.47x	5.35x
Quick Ratio (TTM)	18.47x	4.72x
Debt/Equity (TTM)	0.00x	5.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.34	0.46
52W Performance	-39.4%	-16.3%
YTD Performance	-40.5%	-33.4%
% from 52W High	-53.5%	-48.9%
% from 52W Low	9.4%	84.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.88x
FCF Yield (TTM)	-22.4%	-9.3%
Earnings Yield (TTM)	-22.5%	-23.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-26.4
EV/GP/RG	N/A	0.11
Ticker research	View IMRX research	View TLSI research

Valuation

P/S Ratio

TLSI

5.53x

IMRX

526.64x

EV/FCF

TLSI

-10.14x

IMRX

-3.75x

Growth & revenue

Revenue Growth TTM

TLSI

25.2%

Forward Revenue Growth

IMRX

100.5%

TLSI

40.1%

Profitability & performance

Gross Margin

TLSI

85.8%

IMRX

28.0%

ROE

IMRX

-2715.0%

TLSI

-7902.0%

FCF Yield %

TLSI

-9.3%

IMRX

-22.4%

52-Week Performance

TLSI

-16.3%

IMRX

-39.4%

Detailed metrics comparison

IMRX

Immuneering Corp

TLSI

TriSalus Life Sciences Inc

Market Cap

IMRX$255M

TLSI$249M

Enterprise Value

IMRX$214M

TLSI$236M

Price

IMRX$3.94

TLSI$4.06

P/E Ratio

IMRXN/A

TLSIN/A

P/S Ratio

IMRX526.64x

TLSI5.53x

EV/Sales

IMRX443.99x

TLSI5.24x

EV/EBITDA

IMRX0.00x

TLSI0.00x

P/B Ratio

IMRX1.38x

TLSI40.61x

P/FCF Ratio

IMRXN/A

TLSIN/A

EV/FCF

IMRX-3.75x

TLSI-10.14x

PEG Ratio

IMRXN/A

TLSIN/A

Forward P/E (NTM)

IMRXN/A

TLSIN/A

Forward P/S (NTM)

IMRXN/A

TLSI3.61x

Revenue (TTM)

IMRX$0

TLSI$45M

Revenue Growth (YoY)

IMRXN/A

TLSI25.2%

Forward Rev Growth

IMRX100.5%

TLSI40.1%

Gross Margin (TTM)

IMRX28.0%

TLSI85.8%

Operating Margin (TTM)

IMRX0.0%

TLSI0.0%

EBITDA Margin (TTM)

IMRX0.0%

TLSI-66.4%

Net Margin (TTM)

IMRX0.0%

TLSI-130.2%

FCF Margin (TTM)

IMRXN/A

TLSI-51.6%

Net Income (TTM)

IMRX$-57M

TLSI$-59M

FCF (TTM)

IMRX$-57M

TLSI$-23M

EPS (TTM)

IMRX-$0.89

TLSI-$1.01

ROE (TTM)

IMRX-2715.0%

TLSI-7902.0%

ROA (TTM)

IMRX-2574.0%

TLSI-5499.0%

ROIC (TTM)

IMRX-2715.0%

TLSI-1789.0%

Cash

IMRX$41M

TLSI$46M

Debt

IMRX$0

TLSI$33M

Net Cash/Debt

IMRX$41M

TLSI$13M

Current Ratio (TTM)

IMRX19.47x

TLSI5.35x

Quick Ratio (TTM)

IMRX18.47x

TLSI4.72x

Debt/Equity (TTM)

IMRX0.00x

TLSI5.05x

Debt/Assets (TTM)

IMRX0.0%

TLSI0.0%

Interest Coverage (TTM)

IMRXN/A

TLSIN/A

Net Debt/EBITDA (TTM)

IMRX0.00x

TLSI0.00x

Beta

IMRX0.34

TLSI0.46

52W Performance

IMRX-39.4%

TLSI-16.3%

YTD Performance

IMRX-40.5%

TLSI-33.4%

% from 52W High

IMRX-53.5%

TLSI-48.9%

% from 52W Low

IMRX9.4%

TLSI84.5%

Asset Turnover (TTM)

IMRX0.00x

TLSI0.88x

FCF Yield (TTM)

IMRX-22.4%

TLSI-9.3%

Earnings Yield (TTM)

IMRX-22.5%

TLSI-23.5%

Dividend Yield (TTM)

IMRXN/A

TLSIN/A

Rule of 40

IMRX0.0

TLSI-26.4

EV/GP/RG

IMRXN/A

TLSI0.11

Ticker research

View IMRX research View TLSI research

Metric	IMRX Immuneering Corp	TLSI TriSalus Life Sciences Inc
Market & Valuation
Market Cap	$255M	$249M
Enterprise Value	$214M	$236M
Price	$3.94	$4.06
P/E Ratio	N/A	N/A
P/S Ratio	526.64x	5.53x
EV/Sales	443.99x	5.24x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.38x	40.61x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.75x	-10.14x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.61x
Revenue & Growth
Revenue (TTM)	$0	$45M
Revenue Growth (YoY)	N/A	25.2%
Forward Rev Growth	100.5%	40.1%
Profitability
Gross Margin (TTM)	28.0%	85.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-66.4%
Net Margin (TTM)	0.0%	-130.2%
FCF Margin (TTM)	N/A	-51.6%
Net Income (TTM)	$-57M	$-59M
FCF (TTM)	$-57M	$-23M
EPS (TTM)	-$0.89	-$1.01
ROE (TTM)	-2715.0%	-7902.0%
ROA (TTM)	-2574.0%	-5499.0%
ROIC (TTM)	-2715.0%	-1789.0%
Financial Health
Cash	$41M	$46M
Debt	$0	$33M
Net Cash/Debt	$41M	$13M
Current Ratio (TTM)	19.47x	5.35x
Quick Ratio (TTM)	18.47x	4.72x
Debt/Equity (TTM)	0.00x	5.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.34	0.46
52W Performance	-39.4%	-16.3%
YTD Performance	-40.5%	-33.4%
% from 52W High	-53.5%	-48.9%
% from 52W Low	9.4%	84.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.88x
FCF Yield (TTM)	-22.4%	-9.3%
Earnings Yield (TTM)	-22.5%	-23.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-26.4
EV/GP/RG	N/A	0.11
Ticker research	View IMRX research	View TLSI research